Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31069806 | 1.00 | FFAR1 (0.39) | FFAR1FFAR4CES2CES1EPHX1 | |
| SCHEMBL14894251 | 0.97 | FFAR1 (0.37) | FFAR1FFAR4CES2CES1 | |
| SCHEMBL16979043 | 0.92 | — | — | |
| SCHEMBL7934238 | 0.87 | — | — | |
| SCHEMBL18104919 | 0.79 | FFAR1 (0.34) | FFAR1FFAR4CES2CES1KCNH2 | |
| SCHEMBL4472159 | 0.78 | CES2 (0.35) | FFAR1FFAR4CES2CES1EPHX1 | |
| SCHEMBL31349911 | 0.76 | HAO1 (0.33) | HAO1 | |
| SCHEMBL31586625 | 0.76 | — | — | |
| SCHEMBL10616758 | 0.75 | FFAR1 (0.33) | FFAR1FFAR4CES2CES1KCNH2 | |
| Biphenyl SCHEMBL21409773 | 0.74 | ALDH1A1 (0.44) | CES2CES1EPHX1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120077502-A | Electrolyte, electrochemical device, secondary battery, and lithium ion secondary battery | 大金工业株式会社 | 2025-05-30 | — | — | CN | disclosed |
| CN-119497914-A | Negative electrode, battery, and method for coating battery material | 大金工业株式会社 | 2025-02-21 | — | — | CN | disclosed |
| CN-119487661-A | Secondary battery | 大金工业株式会社 | 2025-02-18 | — | — | CN | disclosed |
| CN-119422259-A | Surface treatment agent for electrode material, positive electrode active material, current collecting foil, negative electrode active material, conductive auxiliary agent, electrode, battery, method for producing positive electrode active material, method for producing current collecting foil, method for producing negative electrode active material, method for producing conductive auxiliary agent, and method for producing electrode | 大金工业株式会社 | 2025-02-11 | — | — | CN | disclosed |
| CN-119340488-A | Electrolyte, electrochemical device, lithium ion secondary battery and assembly | 大金工业株式会社 | 2025-01-21 | — | — | CN | disclosed |
| CN-119318048-A | Electrolyte and secondary battery using the same | 大金工业株式会社 | 2025-01-14 | — | — | CN | disclosed |
| CN-118786542-A | Electrode active material, electrode, electrochemical device, assembly and method | 国立大学法人京都大学 | 2024-10-15 | — | — | CN | disclosed |
| CN-116134060-B | Method for producing aqueous dispersion of fluoroelastomer, and aqueous dispersion | 大金工业株式会社 | 2024-06-18 | — | — | CN | disclosed |
| EP-4353759-A1 | PRODUCTION METHOD FOR AQUEOUS FLUORINE-CONTAINING ELASTOMER DISPERSION, COMPOSITION, AND AQUEOUS DISPERSION | Daikin Industries, Ltd. (JP) | 2024-04-17 | — | — | EP | disclosed |
| CN-117529511-A | Method for producing aqueous dispersion of fluoroelastomer, composition, and aqueous dispersion | 大金工业株式会社 | 2024-02-06 | — | — | CN | disclosed |
| EP-2607348-A2 | Plasminogen Activator Inhibitor-1 Inhibitor | Renascience CO., LTD. (JP) | 2013-06-26 | — | — | EP | disclosed |
| WO-2013062945-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2013-05-02 | — | — | WO | disclosed |
| WO-2013062945-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2013-05-02 | — | — | WO | disclosed |
| EP-2415755-A1 | PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR | Renascience CO., LTD. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20120022080-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | RENASCIENCE CO., LTD. (JP) | 2012-01-26 | — | — | US | disclosed |
| EP-1765816-B1 | SUBSTITUTED 1-PROPIOLYLPIPERAZINES HAVING AN AFFINITY FOR THE MGLUR5 RECEPTOR IN ORDER TO TREAT PAINFUL CONDITIONS | GRUENENTHAL GMBH (DE) | 2010-03-10 | — | — | EP | disclosed |
| US-7300939-B2 | Substituted 1-propiolylpiperazine compounds, their preparation and use | GRUENENTHAL GMBH (DE) | 2007-11-27 | — | — | US | disclosed |
| US-20070112011-A1 | Substituted 1-propiolylpiperazine compounds, their preparation and use | GRUENENTHAL GMBH (DE) | 2007-05-17 | — | — | US | disclosed |
| EP-1765816-A1 | SUBSTITUTED 1-PROPIOLYLPIPERAZINES HAVING AN AFFINITY FOR THE MGLUR5 RECEPTOR IN ORDER TO TREAT PAINFUL CONDITIONS | Grünenthal GmbH (DE) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006002981-A1 | SUBSTITUTED 1-PROPIOLYLPIPERAZINES HAVING AN AFFINITY FOR THE MGLUR5 RECEPTOR IN ORDER TO TREAT PAINFUL CONDITIONS | Grünenthal GmbH (DE) | 2006-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022080-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | SERPINE1, SERPINC1, SERPINB1 | FFAR1 2480/4885FFAR4 3746/4885CES2 4504/4885 |
| US-20070112011-A1 | Substituted 1-propiolylpiperazine compounds, their preparation and use | GRM5, GRIK5, GRM1 | FFAR1 305/4885FFAR4 728/4885CES2 1199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.